What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children

Acute promyelocytic leukemia (APL) accounts for up to 10% of all childhood acute myeloid leukemia cases with a median age at presentation of 9–12 years and a higher incidence in Italy, China, and L...